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Recent data in humans and animals suggest that assisted reproductive technology (ART) might affect the epigenetics
of early embryogenesis and might cause birth defects. We report the first evidence, to our knowledge, that ART is
associated with a human overgrowth syndrome—namely, Beckwith-Wiedemann syndrome (BWS). In a prospective
study, the prevalence of ART was 4.6% (3 of 65), versus the background rate of 0.8% in the United States. A
total of seven children with BWS were born after ART—five of whom were conceived after intracytoplasmic sperm
injection. Molecular studies of six of the children indicate that five of the six have specific epigenetic alterations
associated with BWS—four at LIT1 and one at both LIT1 and H19. We discuss the implications of our finding
that ART is associated with human overgrowth, similar to the large offspring syndrome reported in ruminants.
Introduction
Beckwith-Wiedemann syndrome (BWS [MIM 130650])
is a congenital disorder that involves overgrowth and
neoplasia. The primary features are macrosomia, mac-
roglossia, midline abdominal wall defects, and predis-
position to embryonal cancer (for review, see DeBaun
et al. 2002). BWS has garnered considerable recent in-
terest, because the molecular cause in most cases is epige-
netic, rather than genetic (i.e., it involves stable alterations
in DNA other than the sequence itself). In particular, BWS
has been shown to involve loss of imprinting (LOI) of a
group of imprinted genes on 11p15 (i.e., genes that show
preferential expression from a specific parental allele).
Approximately 15% of patients with BWS have aberrant
methylation and imprinting of H19 (MIM 103280), an
untranslated RNA, and IGF2 (MIM 147470), an auto-
crine growth factor (Weksberg et al. 1993; Reik et al.
1995); almost half of patients with BWS have aberrant
methylation and imprinting of LIT1 (MIM 604115),
an untranslated RNA within the KVLQT1 gene (MIM
192500) (Lee et al. 1999; Smilinich et al. 1999).
LOI can involve hypomethylation or hypermethyla-
tion, depending on the gene. In the case of H19, pa-
tients with BWS who have LOI show hypermethyla-
tion, which likely leads to aberrant activation of IGF2
(Moulton et al. 1994; Steenman et al. 1994). In the
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case of LIT1, patients with BWS show hypomethyla-
tion, which likely leads to aberrant silencing of p57KIP2
(MIM 600856) (Horike et al. 2000; Cleary et al. 2001),
a cyclin-dependent kinase inhibitor. LIT1 is normally
methylated on the maternal allele and unmethylated
on the paternal allele, and, in patients with BWS who
have an imprinting defect, the maternal allele is aber-
rantly hypomethylated. Recently, we performed an epi-
genotype-phenotype study of BWS and found that aber-
rant methylation of LIT1 is specifically associated with
overgrowth and birth defects, and aberrant methylation
ofH19 is specifically associatedwith cancer risk (DeBaun
et al. 2002).
Recent data suggest that assisted reproductive tech-
nology (ART) might affect the epigenetics of early em-
bryogenesis and might cause birth defects—specifically,
Angelman syndrome (MIM 105830) (Cox et al. 2002).
After nuclear transfer or even exposure to in vitro en-
vironments by tissue culture, unusually large offspring
have been born, and this has been referred to as “large
offspring syndrome” (LOS) (Young et al. 1998). Direct
evidence that overgrowth in ART offspring of animals
may be linked to imprinting abnormalities came initially
from studies showing that sheep affected with LOS that
are derived from cultured embryos undergo LOI of the
IGF2 receptor gene (Young et al. 2001), although this
gene is not imprinted in humans. Also, preimplantation
mouse embryos cultured in a chemically defined medium
(M16) undergo epigenetic alterations in the H19, IGF2,
Grb10, and Grb7 genes (Khosla et al. 2001); mouse em-
bryos cultured in Whitten’s medium can undergo LOI of
H19 (Doherty et al. 2000); and cloned mice show vari-
ations in several imprinted genes in the resulting embryos
(Humpherys et al. 2001). Taken together, these results
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suggest that imprinting mutations might occur more fre-
quently in infants that are born after ART. Some data
from human ART also support the idea that birth defects
may be increased. Specifically, low birth weight has been
described after ART (Schieve et al. 2002), and intracy-
toplasmic sperm injection (ICSI) may be associated with
an increased risk of major birth defects (Hansen et al.
2002). A small case-control series of ART/cryopreserved
offspring reported a single case of BWS among 91 cases
(Sutcliffe et al. 1995).
In 1994, we initiated the BWS Registry, to better define
the phenotype, the incidence of cancer, and the genotype-
phenotype correlations, if any. A detailed questionnaire
was used, and clinical features were verified with medi-
cal records and pathology reports. After the start of the
Registry, we noted several patients with BWS who were
born after ART. However, we were unable to determine
if the association was a chance occurrence, since the
original BWS questionnaire did not ask specific ques-
tions regarding ART and since we did not know how
many children with BWS were born after ART. We sub-
sequently designed a new questionnaire, beginning in
2001, to systematically assess the method of conception,
including questions about ART in children with BWS.
Furthermore, to support our hypothesis, we assessed each
patient born after ART for the presence of imprinting
alterations associated with BWS.
Subjects and Methods
We established the BWS Registry in 1994 at the Genetic
Epidemiology Branch of the National Cancer Institute
(NCI), to understand the natural history of this syndrome
and to determine if genotype-phenotype relationships ex-
ist. For those families who agreed to participate, a com-
prehensive questionnaire was completed; informed con-
sent and medical-information–release documents were
obtained. For the purposes of the present study, we de-
fined a patient as having BWS if a clinical diagnosis of
BWS had been made by a physician and the patient had
at least two of the five most common features associated
with BWS (Pettenati et al. 1986): (1) macroglossia, (2)
birth weight and length 190th percentile, (3) hypogly-
cemia in the 1st mo of life, (4) ear creases or ear pits,
and (5) midline abdominal wall defects (e.g., omphalo-
cele, diastasis recti, and umbilical hernia). All positive
phenotypic features were diagnosed by a physician and
were documented in the questionnaire. The local phy-
sician defined “hemihypertrophy.” If a cancer was re-
ported, the diagnosis was confirmed by review of the
final pathology report and medical records.
In June 2001, the Registry was moved to the Wash-
ington University School of Medicine, where the Hu-
man Studies Committee approved the new questionnaire.
We used the same research definition for both the Wash-
ington University BWS Registry and the NCI BWS Reg-
istry. The only difference between the two questionnaires
is that new questions were added that pertained to the
method of conception (natural vs. ART) and the types
of ART—specifically, artificial insemination using bi-
ological father’s sperm, artificial insemination using
donor sperm, in vitro fertilization (IVF) using biolog-
ical mother’s egg and biological father’s sperm, IVF
using biological mother’s egg and donor sperm, IVF
using donor egg and biological father’s sperm, and IVF
using donor egg and donor sperm. If IVF was used,
we asked what type of ICSI was used—ICSI using ejac-
ulated sperm, ICSI using testicular sperm extraction
(TESE), or ICSI using microsurgical epididymal sperm
aspiration. For the reasons described above, we did
not include BWS Registry patients from before 2001
in the prevalence estimate; however, we did include
biological samples from these patients in our analysis
of imprinting alterations.
Genomic DNA was prepared from peripheral-blood
lymphocytes or biopsy samples, by standard proteinase
K digestion and phenol extraction (Cui et al. 1998).
This material is suitable for methylation assays in-
volving DNA. A 1.8-kb PstI fragment of theH19 gene
was analyzed for DNA methylation, by digestion with
PstI and SmaI. For H19 (GenBank accession number
M32053), 5 mg of DNA was digested at 25C over-
night with 40 U of SmaI, followed by an additional
incubation at 37C for 4 h with 40 U of PstI. The
digested DNA was electrophoresed on a 1% agarose
gel, was transferred to Zeta-Probe GT blotting mem-
branes (Biorad), and was hybridized with the 1-kb
PstISmaI fragment isolated from an H19 genomic
clone and oligolabeled with [a-32P]dATP (DeBaun et
al. 2002). For LIT1 (GenBank accession number
AA155639), 5 mg of DNA was digested with BamHI
and NotI at 37C overnight. The digested DNA was
electrophoresed on a 1% agarose gel, was transferred
to Zeta-Probe GT blotting membranes (Biorad), and
was hybridized with an EST 592241 probe oligola-
beled with [a-32P]dATP (DeBaun et al. 2002). Uni-
parental disomy was excluded, as described elsewhere
(DeBaun et al. 2002).
Results
Increased Frequency of IVF among Children with BWS
A total of seven children with BWS were identified as
having been born after ART. All represented sporadic
cases, with no family history. Six of the seven children
were born after IVF using biological mother’s egg and
biological father’s sperm. One child was born after IVF
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Figure 1 Analysis of methylation at the Lit1 CpG island. Meth-
ylation-sensitive Southern blots of LIT1 on DNA from five children
with BWS who were conceived using ART and from a normal control
(NC). The upper band (6.0 kb) is methylated, and the lower band (4.2
kb) is unmethylated.
Table 1
Clinical and Molecular Characteristics of Patients with BWS Who Were Conceived by IVF









1 Yes No Yes Yes Yes No Yes No
2 No No Yes No Yes No Yes No
3 Yes No Yes No No Yes Yes Yes
4 Yes Yes Yes No Yes No Yes No
5 Yes Yes No Yes Yes Yes No No
6 No No Yes Yes Yes Yes ND ND
7 Yes Yes Yes Yes Yes No Yes No
NOTE.—ND p not done (no sample available).
using donor egg and biological father’s sperm. Four of
the seven children were born after ICSI using ejaculated
sperm, one was born after ICSI using TESE, and two
did not involve ICSI.
Three patients were identified from the more recently
establishedWashington University BWSRegistry in 2001,
and the remaining four children were identified from the
NCI BWS Registry. In the Washington University BWS
Registry, the prevalence of ART was 4.6% (3 of 65). In
the United States in 1999, for which the most recent data
are available, there were 0.76% (30,285 of 3,959,417)
live births resulting fromART (see the Centers forDisease
Control [CDC] Web site [CDC’s Reproductive Health In-
formation Source, 1999 Assisted Reproductive Technol-
ogy Success Rates]) (Ventura et al. 2001, p. 25). On the
basis of this background rate, we estimate at least a sixfold
increase in BWS in children born after ART, compared
with the general population. Five of the patientswithBWS
who were born after IVF were conceived by ICSI, and
42% of IVF cycles in the general population were ICSI
related (see the CDC Web site [CDC’s Reproductive
Health Information Source, 1999 Assisted Reproductive
Technology Success Rates]). Despite identifying four pa-
tients born after ART in the NCI BWS Registry, we were
unable to ascertain the prevalence of ART in the NCI
group because of the nonsystematic assessment of ART
in probands ( ).np 279
Clinical Features of Children with BWS Who Were
Born after ART
No clinical feature occurred at a different proportion
than expected when comparing between the children
with BWS who were born after ART and the children
in the BWS Registry as a whole. The frequencies of mac-
rosomia (71% [5 of 7]; ), hypoglycemia (29%Pp .587
[2 of 7]; ), abdominal wall defects (86% [6 ofPp .39
7]; ), macroglossia (86% [6 of 7]; ),Pp .77 Pp .957
ear creases or ear pits (43% [3 of 7]; ), andPp .306
hemihypertrophy (43% [3 of 7]; ) were no dif-Pp .90
ferent than previously reported from the BWS Registry
(DeBaun et al. 2002).
Imprinting Alterations in Patients with BWS Who Were
Born after ART
Samples were obtained from six of seven childrenwith
BWS who were born after ART. Five of the six children
showed abnormal imprinting of LIT1, as indicated by
hypomethylation of the LIT1 differentially methylated
region (DMR) (table 1 and fig. 1). One child of six tested
also showed abnormal imprinting of H19, as indicated
by hypermethylation of theH19DMR (data not shown).
Only one of the six children with BWS who were born
after ART had a normal methylation pattern at both
LIT1 and H19.
Discussion
We have provided the first evidence that ART is associated
with a human overgrowth syndrome, BWS. In the Wash-
ington University BWS Registry, ∼5% (3 of 65) of the
children with BWS were born after ART, whereas, if no
association existed, we would have expected no children
with BWS to have been born after ART, suggesting at
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least a sixfold increase in the rate of ART in children
with BWS. Further support for the association between
BWS and ART is based on the observation that four
additional patients with BWS in the NCI Registry were
conceived after ART—an observation made despite the
fact that this Registry was not designed to determine if
there was an association between BWS and ART. We
believe that a 5% prevalence of children conceived after
ART is most likely an underestimate, in that the BWS
questionnaire has asked specific questions regarding
ART in only 2 of the past 8 years of the BWS Registry’s
existence. In addition to the epidemiologic evidence that
ART is associated with BWS, we have shown biological
data strengthening this association. Five of the six chil-
dren with BWSwhowere born after ART had imprinting
mutations of the LIT1 and/or H19 genes, two distinct
methylation alterations specific to BWS. These results
confirm the clinical diagnosis of BWS and demonstrate
a specific imprinting defect in most patients with BWS
who were born after ART.
On the basis of our findings, as well as the observation
that Angelman syndrome occurred after ICSI (Cox et
al. 2002), sufficient evidence exists to suggest that some
aspect of the ART procedure increases the frequency of
epigenetic abnormalities leading to congenital malfor-
mation syndromes. The incidence of cancer in children
with BWS who are !4 years of age is 0.02 per 100 patient
years (DeBaun and Tucker 1998). Thus, the small num-
ber of patients with BWS who were born after ART did
not allow assessment of an association between ART and
cancer. However, given the known association between
BWS, cancer, and an increased frequency of H19 meth-
ylation abnormalities in children with BWS, we postulate
that ART is associated with embryonal cancers of child-
hood in which methylation abnormalities of H19 have
been implicated (Wilms tumor, hepatoblastoma, and
rhabdomyosarcoma).
In both Angelman syndrome (Cox et al. 2002) and
BWS after ICSI, it is the maternal allele that is affected
(unmethylated). This makes it unlikely that the problem
is related to sperm differentiation. It is more likely that
ICSI or some other aspect of the ART used disturbsmeth-
ylation of the maternal genome in the oocyte or early
embryo. Given that 42% of ART procedures in the gen-
eral population are ICSI related, we cannot discriminate
between ICSI and other aspects of the procedure in the
association with BWS; this must come from a large-
scale study.
As expected when a rare congenital malformation syn-
drome is studied with a registry, certain limitations are
inherent in our analysis. We could not exclude the pos-
sibility that parents of children with BWS who were born
after ART were more likely to join the Registry than
parents born after natural birth were. However, we
made no effort to recruit parents of children born after
ART for the Washington University BWS Registry. An-
other limitation is the small number of patients in the
Washington University BWS Registry ( ), raisingnp 65
the possibility of a chance association between ART and
BWS. Although the Washington University BWS Reg-
istry has a small number of patients, we created the new
questionnaire specifically to test the hypothesis that BWS
was associated with ART. We believe strongly that our
data reflect a real association and warrant further in-
vestigation into the biological basis, since, at this point,
we do not know what specific step (or steps) of ART
is responsible for the association with BWS. Potential
factors could include culture conditions for the ovum,
length of exposure to specific media or growth factors
therein, the stage of differentiation of sperm at the time
of ICSI, or ICSI itself, since some of the patients had
undergone ICSI as part of the ART procedure.
The clinical implications of our finding that ART is
associated with a congenital malformation syndrome,
in addition to recent data from other studies, are un-
known at present. Further biological studies will be re-
quired in order to understand the pathogenesis of this
association and what precautions can be taken to pre-
vent the occurrence of these syndromes.
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